NO750733L - - Google Patents

Info

Publication number
NO750733L
NO750733L NO750733A NO750733A NO750733L NO 750733 L NO750733 L NO 750733L NO 750733 A NO750733 A NO 750733A NO 750733 A NO750733 A NO 750733A NO 750733 L NO750733 L NO 750733L
Authority
NO
Norway
Prior art keywords
compound
carbon atoms
formula
straight
branched
Prior art date
Application number
NO750733A
Other languages
English (en)
Norwegian (no)
Inventor
K G Claeson
S I Gustavsson
H G Oresten
L-I Wickstroem
R L Brattsand
Original Assignee
Astra Bofors Nobelpharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Bofors Nobelpharma Ab filed Critical Astra Bofors Nobelpharma Ab
Publication of NO750733L publication Critical patent/NO750733L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO750733A 1974-03-06 1975-03-05 NO750733L (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7402962A SE378815B (cs) 1974-03-06 1974-03-06

Publications (1)

Publication Number Publication Date
NO750733L true NO750733L (cs) 1975-09-09

Family

ID=20320427

Family Applications (1)

Application Number Title Priority Date Filing Date
NO750733A NO750733L (cs) 1974-03-06 1975-03-05

Country Status (10)

Country Link
JP (1) JPS50117777A (cs)
BE (1) BE826349A (cs)
DE (1) DE2506908A1 (cs)
DK (1) DK88575A (cs)
FI (1) FI750512A (cs)
FR (1) FR2262987A1 (cs)
LU (1) LU71983A1 (cs)
NL (1) NL7502688A (cs)
NO (1) NO750733L (cs)
SE (1) SE378815B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163784A (en) * 1978-03-09 1979-08-07 Pfizer Inc. Heterocyclylcarbonyl derivatives of urea, agents for dissolution of gallstones

Also Published As

Publication number Publication date
DE2506908A1 (de) 1975-09-18
SE378815B (cs) 1975-09-15
FR2262987A1 (cs) 1975-10-03
NL7502688A (nl) 1975-09-09
JPS50117777A (cs) 1975-09-16
SE7402962L (cs) 1975-09-08
LU71983A1 (cs) 1976-02-04
DK88575A (cs) 1975-09-07
BE826349A (fr) 1975-09-08
FI750512A (cs) 1975-09-07

Similar Documents

Publication Publication Date Title
EP1163224B1 (en) N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
JP4164645B2 (ja) Ｄｇａｔ阻害剤
RU2191776C2 (ru) Эрголиновые производные, способ их получения, фармацевтическая композиция
JPH0725728B2 (ja) Ｎ‐〔〔（２，６‐ジ置換）フエニル〕‐ｎ′‐ジアリールアルキル〕尿素
EP0245687B1 (en) Substituted pyrimidine amides of oleic or linoleic acid as inhibitors of acyl-coa cholesterol acyltransferase
EP4181921A1 (en) Crystalline forms of a selective c-kit kinase inhibitor
CS262690B2 (en) Process for preparing 1-/hydroxystyryl/-5h-2,3-benzodiazepines
IE891908L (en) Novel esters
JPS6322520A (ja) 学習促進・記憶増強用薬剤
NO317649B1 (no) Optisk aktiv pyridyl-4H-1,2,4-oksazdiazinderivat og dets anvendelse ved behandling av karsykdommer
EP0064388B1 (en) Retard oral pharmaceutical compositions
CN115925699B (zh) 具有镇痛活性的稠环化合物及其制备方法与用途
NO750733L (cs)
EP3984993A1 (en) Use of aminothiol compounds as cerebral nerve or heart protective agent
JP2023514291A (ja) Ｊａｋ阻害剤の結晶形およびその使用
EP0228314A2 (en) Use of ethanol/amine derivatives in treating or preventing hyperlipemia
JP6843845B2 (ja) １，４−ジ−（４−メチルチオフェニル）−３−フタロイルアゼチジン−２−オンおよびその誘導体
US4871758A (en) Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
JP2577994B2 (ja) 脳血流増加剤
EP0047358B1 (en) Indol acetic derivatives, process for producing the same and pharmaceutical compositions comprising the same
EP0293146A1 (en) Benzofuro [3,2-c] quinoline compounds
CN116693603A (zh) 一种治疗炎症疾病的双环稠合化合物及其用途
NO743815L (cs)
JPS6148831B2 (cs)
US4443457A (en) Aminocrot onylpyridine N-oxides useful as adjuncts to radiation therapy